Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 279Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4AcipHex

02 1Aciphex

03 7Pariet

PharmaCompass

01

Brand Name : AcipHex

Rabeprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : AcipHex

arrow
2024 ACI Convention
Not Confirmed

Rabeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2020 Revenue in Millions : 38

2019 Revenue in Millions : 39

Growth (%) : -2

blank

02

Brand Name : Pariet

Rabeprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pariet

arrow
2024 ACI Convention
Not Confirmed

Rabeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2020 Revenue in Millions : 188

2019 Revenue in Millions : 200

Growth (%) : -6

blank

03

Brand Name : Pariet

Rabeprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pariet

arrow
2024 ACI Convention
Not Confirmed

Rabeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2021 Revenue in Millions : 60

2020 Revenue in Millions : 180

Growth (%) : -64

blank

04

Brand Name : AcipHex

Rabeprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : AcipHex

arrow
2024 ACI Convention
Not Confirmed

Rabeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2021 Revenue in Millions : 24

2020 Revenue in Millions : 36

Growth (%) : -30

blank

05

Brand Name : Pariet

Rabeprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pariet

arrow
2024 ACI Convention
Not Confirmed

Rabeprazole

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2022 Revenue in Millions : 12

2021 Revenue in Millions : 60

Growth (%) : -80

blank

06

Brand Name : Pariet

Rabeprazole Sodium

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pariet

arrow
2024 ACI Convention
Not Confirmed

Rabeprazole Sodium

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2023 Revenue in Millions : 129

2022 Revenue in Millions : 169

Growth (%) : -14

blank

07

Brand Name : Pariet

Rabeprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pariet

arrow
2024 ACI Convention
Not Confirmed

Rabeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2017 Revenue in Millions : 256

2016 Revenue in Millions : 285

Growth (%) : -10

blank

08

Brand Name : Pariet

Rabeprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pariet

arrow
2024 ACI Convention
Not Confirmed

Rabeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 205

2017 Revenue in Millions : 240

Growth (%) : -15%

blank

09

Brand Name : AcipHex

Rabeprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : AcipHex

arrow
2024 ACI Convention
Not Confirmed

Rabeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2017 Revenue in Millions : 62

2016 Revenue in Millions : 68

Growth (%) : -8

blank

10

Brand Name : Aciphex

Rabeprazole

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Aciphex

arrow
2024 ACI Convention
Not Confirmed

Rabeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 44

2017 Revenue in Millions : 59

Growth (%) : -25%

blank